EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease

Rania Chermiti, Stéphane Burtey iD, Laetitia Dou iD

Journal of Clinical Medicine · 26.11.2024 · 13 (23) · 7149

DOI: 10.3390/jcm13237149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.11.2024. Verfasst von Rania Chermiti und 2 weiteren Autor:innen. Beteiligte Einrichtung: C2VN, Aix-Marseille University, INSERM, INRAE, 13005 Marseille, France. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is a major complication of chronic kidney disease (CKD), despite improvements in patient care. Vascular inflammation is a crucial process in the pathogenesis of CVD and a critical factor in the cardiovascular complications in CKD patients. CKD promotes a pro-inflammatory environment that impacts the vascular wall, leading to endothelial dysfunction, increased oxidative stress, and vascular remodeling. The uremic toxins that accumulate as kidney function declines are key contributors to vascular inflammatory processes. Our review will examine how CKD leads to vascular inflammation, paving the way to CVD. We will provide an overview of the mechanisms of vascular inflammation induced by uremic toxins, with a particular focus on those derived from tryptophan metabolism. These toxins, along with their receptor, the aryl hydrocarbon receptor (AHR), have emerged as key players linking inflammation and thrombosis. A deeper understanding of the mechanisms underlying inflammation in CKD, particularly those driven by uremic toxins, could reveal valuable therapeutic targets to alleviate the burden of CVD in CKD patients.

Schlagwörter

Stichwörter der Autor:innen

aryl hydrocarbon receptorcardiovascular diseasechronic kidney diseaseuremic toxinsvascular inflammation

Autor:innen und Institutionen

  • C2VN, Aix-Marseille University, INSERM, INRAE, 13005 Marseille, France.
  • Centre de Néphrologie et Transplantation Rénale, APHM, Hôpital Conception, 13005 Marseille, France.

ORCID-Profile: Stéphane Burtey, Laetitia Dou

Zitieren

APA

Chermiti, R., Burtey, S., & Dou, L. (2024). Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease. Journal of Clinical Medicine, 13(23), 7149. https://doi.org/10.3390/jcm13237149

Vancouver

Chermiti R, Burtey S, Dou L. Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease. Journal of Clinical Medicine. 2024;13(23):7149. doi:10.3390/jcm13237149

BibTeX
@article{Chermiti2024,
  author = {Chermiti, Rania and Burtey, Stéphane and Dou, Laetitia},
  title = {Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {7149},
  doi = {10.3390/jcm13237149}
}
Kostenlos starten →